Galantamine

Galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
Do not take if: Galantamine is contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation.

What it is used for

Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.

Side effects, and when to stop

Serious adverse reactions are discussed in more detail in the following sections of the labeling:

Serious Skin Reactions
Cardiovascular Conditions
Gastrointestinal Conditions
Genitourinary Conditions
Neurological Conditions
Pulmonary Conditions
Deaths in Subjects with Mild cognitive impairment (MCI)

Who should not take it

Galantamine is contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Galantamine; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/galantamine
APA 7th: sofidex. (2026, August 2). Galantamine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/galantamine
AMA 11th: Galantamine. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/galantamine

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.